Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders - Wikidata - awgldk - TriplyDB

Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders

Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders

http://www.wikidata.org/entity/Q34511301

about

Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies Biomarkers for nutrient intake with focus on alternative sampling techniques Pentadecanoic and Heptadecanoic Acids: Multifaceted Odd-Chain Fatty Acids.Even- and odd-chain saturated fatty acids in serum phospholipids are differentially associated with adipokines Metabolomics to Explore Impact of Dairy Intake Exploring the association of dairy product intake with the fatty acids C15:0 and C17:0 measured from dried blood spots in a multipopulation cohort: Findings from the Food4Me study.Content and Composition of Branched-Chain Fatty Acids in Bovine Milk Are Affected by Lactation Stage and Breed of Dairy Cow.Metabolomics in childhood diabetes.Milk fat biomarkers and cardiometabolic disease Plasma fatty acids as predictors of glycaemia and type 2 diabetes.Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high-fat diet-induced obesity.Reply to M Lankinen and U Schwab and WMN Ratnayake.Concerns about the use of 15:0, 17:0, and trans-16:1n-7 as biomarkers of dairy fat intake in recent observational studies that suggest beneficial effects of dairy food on incidence of diabetes and stroke Biomarkers of dairy fat Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study.Alteration of Rumen Bacteria and Protozoa Through Grazing Regime as a Tool to Enhance the Bioactive Fatty Acid Content of Bovine Milk.The dairy fat paradox: Whole dairy products may be healthier than we thought.Biomarker of food intake for assessing the consumption of dairy and egg products The association between dairy product intake and cardiovascular disease mortality in Chinese adults

P2860

Q22242059-542D5E74-3132-4E3F-B4FC-E6E861321DA4 Q26739783-37F326F6-D9DF-47E9-A9F6-9B07764A7BD8 Q31115088-C2D64E48-4521-4788-868E-8454BF5C018B Q33732047-63CC52FD-ABD4-47F9-B586-59F4B27C463D Q35809032-957A36BC-8D11-45A5-A501-01A5DF5EEE49 Q35871914-4A87A0B2-CB00-4EAE-8BE6-87F7037F85CD Q35941423-CB06F807-EA1D-4BCC-985B-877DA6FBD0E7 Q36436985-97FF2810-97F4-46F4-A760-C8A45C0840DC Q37558456-7F1C7EB2-AA24-4963-8D02-0692B570A445 Q40639189-2F223711-C7A3-4824-AD54-739A4336B2B8 Q40818026-98E8BCEB-5FB4-497F-996B-2C690202E2BD Q42588921-0BA2D403-A42D-4D1A-A24D-8280FB65A4EB Q42588925-D5ED9A3F-4DF3-4EA1-BB06-1AC7CC84BFFE Q42588939-7C3D06DB-88AE-4466-A084-41209A4073C1 Q47336123-6E95E2FD-0B19-4695-A38A-EA40254C82C4 Q47776089-2BB5EEF1-5110-4DE1-BD1B-7AB5178F3D23 Q54963857-7B66D625-2F3A-475A-98E0-86968AC6BEE8 Q55314607-179EADCE-CCDC-465B-91FE-E5DE469D92B8 Q57064967-5BE6506A-661A-40E6-8EE8-ABE268789E91 Q58396506-E937F5B1-82C3-48E7-8D62-8DBEDC2A0418

P2860

Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders

http://www.wikidata.org/entity/Q34511301

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@ast

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@en

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@nl

type

label

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@ast

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@en

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@nl

prefLabel

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@ast

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@en

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@nl

P1433

Q34511301-422D7098-51FB-4B8D-93F8-43EE1D386C7E

P1476

Q34511301-F6021F7B-80EF-4393-A531-37C36F339733

P2093

Q34511301-11191D24-2938-4B94-B4C3-5C4968BFAD7D

Q34511301-48C589E0-5977-4A53-90FC-6A1AE32C6147

Q34511301-944AD9AE-27D3-4CF1-BBA2-70E6021087C0

Q34511301-A2DE0762-A96A-489E-AC31-37563BB30205

Q34511301-BFD0D2EC-9A53-454C-9F0E-B3CC378BAD82

Q34511301-F323FE92-72F2-4D0D-B9FA-86D1631A802B

Q34511301-FC279FCF-7AE1-48D7-9F31-340E1B9FBA00

P2860

Q34511301-04352441-384C-4336-A9CC-B5B7039E3099

Q34511301-05D77706-AF25-4712-96B9-56EB915287E7

Q34511301-0F93A26A-A331-4862-B526-C818570134FD

Q34511301-12D1A5A1-6A97-4285-98BD-5DE0A27A2278

Q34511301-18BFB9E6-AE00-4300-8A5D-F72810429A4D

Q34511301-23D1D081-3500-4EE9-B816-C7F003CF4092

Q34511301-28457965-354A-486F-A102-BFF9E934008B

Q34511301-289EF3C0-69B0-4326-89EA-7D26F3BA4F62

Q34511301-2994A75D-165D-43DB-B84F-B7749E8571F3

Q34511301-305DA29E-7297-42B6-A64E-65F7A9D85DC6

P304

Q34511301-A3FFF78F-9DA5-4EEE-9A0B-01CEF89F4A5D

P31

Q34511301-0145A079-C7DC-4FC8-ABA3-AEC2849733C2

P356

Q34511301-0D0C6E2D-4E1F-4DD1-8B01-FCAE30E6078E

P407

Q34511301-A8C69E74-ED1D-45AF-A44B-7ED05FF5A5B6

P433

Q34511301-CA61A3DD-537E-4A44-9CA0-6A54863E2901

P478

Q34511301-8C28A36C-2700-4BC0-BC3F-898A14B700CB

P50

Q34511301-F88A90C6-C181-4811-84E4-3420C75C470B

P577

Q34511301-327049DD-F514-4C05-8237-33CCADEF19F3

P698

Q34511301-21313127-0A8F-45C0-945D-A00367CC44B7

P921

Q34511301-1C9EAAAF-B305-4521-9143-B9DEA50BC2D5

P932

Q34511301-846885B3-5CCA-4C0F-842F-E85E0CE15A04

P356

AJCN.114.092544

P1433

The American Journal of Clinical Nutrition

P1476

Serum pentadecanoic acid (15:0 ...... s and its underlying disorders

@en

P2093

Angela D Liese

http://www.w3.org/2001/XMLSchema#string

Anthony J Hanley

http://www.w3.org/2001/XMLSchema#string

Carlos Lorenzo

http://www.w3.org/2001/XMLSchema#string

Ingrid D Santaren

http://www.w3.org/2001/XMLSchema#string

Marian J Rewers

http://www.w3.org/2001/XMLSchema#string

Steven M Haffner

http://www.w3.org/2001/XMLSchema#string

Steven M Watkins

http://www.w3.org/2001/XMLSchema#string

P2860

Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk

Diagnosis and Classification of Diabetes Mellitus

The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence

Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study

A simple method for the isolation and purification of total lipides from animal tissues

Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans

Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study.

Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors.

Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)

Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

P304

1532-1540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3945/AJCN.114.092544

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Lynne E Wagenknecht

P577

2014-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25411288

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4232018

http://www.w3.org/2001/XMLSchema#string